Literature DB >> 31177393

Factors impacting on discordance with treatment plan in head and neck cancer patients: a retrospective, population-based cohort study.

Ya-Lan Chang1,2, Shu-Chu Lee3, Chun-Ta Liao4, Chao-Hui Wang1,2, Yu-Fen Lin1, Shu-Ching Chen5,6,7.   

Abstract

PURPOSE: The aims of this study were to identify the factors and reasons impacting discordance with the treatment plan in head and neck cancer (HNC) patients and compare the differences between the concordance group and the discordance group.
METHODS: This secondary analysis was conducted from population-based data from Taiwan collected from January 1, 2016, to June 30, 2018. Logistic regression analysis was used to identify the factors related to discordance with the treatment plan.
RESULTS: We examined 1095 HNC patients, 12.1% of whom were discordant with treatment. Patients with advanced cancer stage, old age, and treatment plans of best supportive care (BSC) or surgery combined with radiation (RT), chemotherapy (CT), or chemoradiation (CCRT) were more likely to have discordance with their treatment plan. Of the 133 patients who were discordant with their treatment plan, the top reasons were as follows: "patients or their family considered patients' poor physical condition (chronic disease or unstable systemic disease), difficulty in enduring any condition likely to cause physical discomfort from disease treatment," "inconvenient transportation," and "disease progression."
CONCLUSIONS: Patients' cancer stage, age, and types of treatment plans recommended significantly influenced discordance with treatment plan. Poor physical condition was the major reason for discordance with the treatment plan. Patients in the concordance group were significantly more likely than those in the discordance group to be younger than 65 years, have less advanced cancer stage, and be recommended to receive surgery rather than any other regimen. Multidisciplinary team care can help patients make positive decisions about treatment.

Entities:  

Keywords:  Head and neck cancer; Interdisciplinary health team; Medical care team; Patient noncompliance; Therapeutic compliance; Treatment adherence and compliance

Mesh:

Year:  2019        PMID: 31177393     DOI: 10.1007/s00520-019-04904-z

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  27 in total

1.  Untreated head and neck cancer in Korea: a national cohort study.

Authors:  Hyo Geun Choi; Bumjung Park; Soon-Hyun Ahn
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-14       Impact factor: 2.503

2.  Colorectal cancer in Taiwan: A case-control retrospective analysis of the impact of a case management programme on refusal and discontinuation of treatment.

Authors:  Ting-Yu Chiang; Chao-Hui Wang; Yu-Fen Lin; Jeng-Fu You; Jinn-Shiun Chen; Shu-Ching Chen
Journal:  J Adv Nurs       Date:  2017-10-04       Impact factor: 3.187

3.  Health-related quality of life and satisfaction with case management in cancer survivors.

Authors:  Ya-Hui Hsu; Hsiu-Ying Chai; Yu-Fen Lin; Chao-Hui Wang; Shu-Ching Chen
Journal:  J Clin Nurs       Date:  2017-06-20       Impact factor: 3.036

4.  Association between multidisciplinary team care approach and survival rates in patients with oral cavity squamous cell carcinoma.

Authors:  Chun-Ta Liao; Chung-Jan Kang; Li-Yu Lee; Chuen Hsueh; Chien-Yu Lin; Kang-Hsing Fan; Hung-Ming Wang; Shu-Hang Ng; Chih-Hung Lin; Chung-Kan Tsao; Tuan-Jen Fang; Shiang-Fu Huang; Kai-Ping Chang; Ya-Lan Chang; Lan Yan Yang; Tzu-Chen Yen
Journal:  Head Neck       Date:  2016-02-18       Impact factor: 3.147

Review 5.  Interventions to enhance medication adherence.

Authors:  R B Haynes; X Yao; A Degani; S Kripalani; A Garg; H P McDonald
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

6.  Concordance of Patient and Physician Perceptions of Care in an Orthopedic Clinic.

Authors:  Kelly Zhang; Charles Day; Matthew L Iorio
Journal:  Orthopedics       Date:  2017-04-24       Impact factor: 1.390

7.  The content and amount of information given by medical oncologists when telling patients with advanced cancer what their treatment options are. palliative chemotherapy and watchful-waiting.

Authors:  C G Koedoot; F J Oort; R J de Haan; P J M Bakker; A de Graeff; J C J M de Haes
Journal:  Eur J Cancer       Date:  2004-01       Impact factor: 9.162

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

9.  Benefits, barriers and opinions on multidisciplinary team meetings: a survey in Swedish cancer care.

Authors:  Linn Rosell; Nathalie Alexandersson; Oskar Hagberg; Mef Nilbert
Journal:  BMC Health Serv Res       Date:  2018-04-05       Impact factor: 2.655

10.  Factors associated with lung cancer patients refusing treatment and their survival: a national cohort study under a universal health insurance in Taiwan.

Authors:  Hsiu-Ling Huang; Pei-Tseng Kung; Chang-Fang Chiu; Yueh-Hsin Wang; Wen-Chen Tsai
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

View more
  3 in total

1.  Adherence to Multidisciplinary Tumor Board Recommendations in Patients With Curable Esophageal and Gastric Cancers.

Authors:  Joel Jia Yi Soon; Yue Zhao; Nicholas Brian Shannon; Jeremy Tian Hui Tan
Journal:  J Gastrointest Cancer       Date:  2022-06-27

2.  Factors Associated with Refusal or Discontinuation of Treatment in Patients with Bladder Cancer: A Cohort Population-Based Study in Taiwan.

Authors:  Nai-Tan Chang; Ying-Hsu Chang; Yu-Tung Huang; Shu-Ching Chen
Journal:  Int J Environ Res Public Health       Date:  2021-01-13       Impact factor: 3.390

Review 3.  Barriers to Adherence to Cancer Treatments Among Head and Neck Cancer Patients.

Authors:  Jennifer Lynn Miller; Julianne Evers
Journal:  J Adv Pract Oncol       Date:  2022-07-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.